维贝格龙各版本价格一览

Vibegron is clinically used to treat overactive bladder (OAB), which can effectively relieve symptoms of urinary urgency, frequency and urge urinary incontinence. Currently, the drug has not been approved for marketing in mainland China, nor has it been included in the medical insurance list.

1. Price list of various versions of Vibegroron

The Vibegroron currently on the market is a generic drug produced by Lucius Pharmaceuticals in Laos. The price is 75mg*30 tablets/box and the price is about US$158. Since Vibegroron is an imported drug, the drug price is affected by factors such as exchange rates and is uncertain. The above prices are for reference only.

Patients can purchase Vibegroron with a doctor’s prescription in countries that have approved Vibegroron for marketing (such as Laos and the United States), or on some compliant online platforms. Patients are required to upload a valid prescription and verify the platform’s qualifications.

The outer packaging of authentic Vibegeron should be printed with clear production batch number, expiration date and manufacturer information, such as the logo of Lucius Pharmaceuticals in Laos. Patients also need to observe the characteristics of the tablets. Genuine Vibegeron is a light green oval film-coated tablet, with "V75" debossed printed on one side and smooth and traceless on the other side. Beware of buying fake and shoddy drugs.

2. How to store Vibegeron

Verbegeron is an oral tablet and requires strict storage conditions. Improper storage may cause the drug to fail or deteriorate. After purchasing Vibegroron, patients must follow the following guidelines to store the drug correctly.

1. Packaging protection

Vibegron should be placed in the original aluminum foil packaging to prevent the tablets from direct contact with air or light. If you need to repackage after opening, you should use light-proof sealed containers and mark the date of opening.

2. Temperature control

Unopened Vibergaron should be stored in an environment of 20°C to 25°C, and is allowed to be exposed to 15°C to 30°C for a short period of time. Avoid placing Vibergaron in high-temperature environments such as in cars, next to heaters, or in freezing environments such as the freezer layer of refrigerators to prevent degradation of drug ingredients.

3. Moisture-proof and anti-pollution

Vibegron should be stored in a dry place, away from humid environments such as bathrooms. Clean your hands before taking the medicine to avoid contaminating remaining tablets.

All medicines at home must be stored in a high place or in a locked cabinet out of the reach of children. Vibegroron is valid for 24 months. Expired medicines must be disposed of according to medical waste regulations and are prohibited from continued use.

3. Usage and Dosage of Vibegroron

The efficacy of Vibegeron is closely related to the medication method, and patients must strictly follow the dosage and dosage specifications.

1. Standard dose and frequency

The recommended dose of Vibegroron for adult patients is 75 mg orally once a day. The specific dosage varies from person to person. Please consult the attending physician. Vibegrolone tablets should be swallowed whole, with or without food. Elderly patients and those with mild to moderate hepatic and renal insufficiency do not need to adjust the dose.

2. How to take

Vibegroron needs to be swallowed whole and taken with at least a glass of water to avoid the pills remaining in the esophagus and causing irritation. If you have difficulty swallowing, crush the tablets and mix with a tablespoon (about 15 mL) of applesauce. Take it immediately with warm water. Do not prepare or store it in advance.

3. Missed dose recovery

Avoid missing a dose of Vibegroron. If a dose is missed, it should be taken as soon as possible. If the missed dose is found to be close to the time of the next dose, skip this time and do not take double doses.

During the medication period, patients should avoid changing the dosage or combining it with other drugs. They need regular follow-up visits to record the number of urgent urinations, frequency of nocturia and other indicators to help doctors evaluate the efficacy and adjust the plan in a timely manner.